304 related articles for article (PubMed ID: 27881732)
1. Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells.
Chan TS; Hsu CC; Pai VC; Liao WY; Huang SS; Tan KT; Yen CJ; Hsu SC; Chen WY; Shan YS; Li CR; Lee MT; Jiang KY; Chu JM; Lien GS; Weaver VM; Tsai KK
J Exp Med; 2016 Dec; 213(13):2967-2988. PubMed ID: 27881732
[TBL] [Abstract][Full Text] [Related]
2. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
[TBL] [Abstract][Full Text] [Related]
3. IFNβ1 secreted by breast cancer cells undergoing chemotherapy reprograms stromal fibroblasts to support tumour growth after treatment.
Maia A; Gu Z; Koch A; Berdiel-Acer M; Will R; Schlesner M; Wiemann S
Mol Oncol; 2021 May; 15(5):1308-1329. PubMed ID: 33476079
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
5. Therapy-activated stromal cells can dictate tumor fate.
Kerbel RS; Shaked Y
J Exp Med; 2016 Dec; 213(13):2831-2833. PubMed ID: 27881735
[TBL] [Abstract][Full Text] [Related]
6. An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells.
Jia D; Li L; Andrew S; Allan D; Li X; Lee J; Ji G; Yao Z; Gadde S; Figeys D; Wang L
Cell Death Dis; 2017 Jul; 8(7):e2932. PubMed ID: 28703802
[TBL] [Abstract][Full Text] [Related]
7. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
9. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists.
Erin N; Nizam E; Tanrıöver G; Köksoy S
Breast Cancer Res Treat; 2015 Feb; 150(1):57-69. PubMed ID: 25682075
[TBL] [Abstract][Full Text] [Related]
10. Stromal cells in tumor microenvironment and breast cancer.
Mao Y; Keller ET; Garfield DH; Shen K; Wang J
Cancer Metastasis Rev; 2013 Jun; 32(1-2):303-15. PubMed ID: 23114846
[TBL] [Abstract][Full Text] [Related]
11. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.
Boelens MC; Wu TJ; Nabet BY; Xu B; Qiu Y; Yoon T; Azzam DJ; Twyman-Saint Victor C; Wiemann BZ; Ishwaran H; Ter Brugge PJ; Jonkers J; Slingerland J; Minn AJ
Cell; 2014 Oct; 159(3):499-513. PubMed ID: 25417103
[TBL] [Abstract][Full Text] [Related]
12. Inter- and intra-cellular mechanism of NF-kB-dependent survival advantage and clonal expansion of radio-resistant cancer cells.
Yu H; Aravindan N; Xu J; Natarajan M
Cell Signal; 2017 Feb; 31():105-111. PubMed ID: 28069440
[TBL] [Abstract][Full Text] [Related]
13. Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling.
Sun Y; Yang D; Xi L; Chen Y; Fu L; Sun K; Yin J; Li X; Liu S; Qin Y; Liu M; Hou Y
Cell Death Dis; 2018 Jan; 9(2):122. PubMed ID: 29374150
[TBL] [Abstract][Full Text] [Related]
14. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.
Chandrasekar B; Melby PC; Sarau HM; Raveendran M; Perla RP; Marelli-Berg FM; Dulin NO; Singh IS
J Biol Chem; 2003 Feb; 278(7):4675-86. PubMed ID: 12468547
[TBL] [Abstract][Full Text] [Related]
15. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
Kerbel RS; Shaked Y
Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.
Schauer IG; Zhang J; Xing Z; Guo X; Mercado-Uribe I; Sood AK; Huang P; Liu J
Neoplasia; 2013 Apr; 15(4):409-20. PubMed ID: 23555186
[TBL] [Abstract][Full Text] [Related]
17. Integrative Omics Analysis Revealed that Metabolic Intervention Combined with Metronomic Chemotherapy Selectively Kills Cancer Cells.
Shao C; Lu W; Wan N; Wu M; Bao Q; Tian Y; Lu G; Wang N; Hao H; Ye H
J Proteome Res; 2019 Jun; 18(6):2643-2653. PubMed ID: 31094201
[TBL] [Abstract][Full Text] [Related]
18. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
[TBL] [Abstract][Full Text] [Related]
19. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice.
Elkabets M; Gifford AM; Scheel C; Nilsson B; Reinhardt F; Bray MA; Carpenter AE; Jirström K; Magnusson K; Ebert BL; Pontén F; Weinberg RA; McAllister SS
J Clin Invest; 2011 Feb; 121(2):784-99. PubMed ID: 21266779
[TBL] [Abstract][Full Text] [Related]
20. Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis.
Kim HM; Jung WH; Koo JS
J Transl Med; 2015 Jul; 13():222. PubMed ID: 26163388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
